Last update 08 May 2025

RW-108

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms-
Target
A2aR x A2bR
Action
inverse agonists
Mechanism
A2aR inverse agonists(Adenosine A2a receptor inverse agonists), A2bR inverse agonists(Adenosine A2b receptor inverse agonists)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Advanced Triple-Negative Breast CarcinomaMetastatic Triple-Negative Breast Carcinoma
Inactive Indication-
Originator Organization
Riverwalk Therapeutics, Inc.Riverwalk Therapeutics, Inc.
Texas University of Health Center at San Antonio
Active Organization
Texas University of Health Center at San AntonioRiverwalk Therapeutics, Inc.Riverwalk Therapeutics, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with RW-108
Login to view more data
100 Translational Medicine associated with RW-108
Login to view more data
100 Patents (Medical) associated with RW-108
Login to view more data
100 Deals associated with RW-108
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Triple-Negative Breast CarcinomaPreclinical
United States
Riverwalk Therapeutics, Inc.Riverwalk Therapeutics, Inc.
30 Apr 2025
Advanced Triple-Negative Breast CarcinomaPreclinical
United States
Texas University of Health Center at San Antonio
30 Apr 2025
Metastatic Triple-Negative Breast CarcinomaPreclinical
United States
Texas University of Health Center at San Antonio
30 Apr 2025
Metastatic Triple-Negative Breast CarcinomaPreclinical
United States
Riverwalk Therapeutics, Inc.Riverwalk Therapeutics, Inc.
30 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free